Wai‐Kay Seto

Risk estimation for hepatocellular carcinoma in chronic hepatitis B (REACH-B): development and validation of a predictive score

Hwai‐I Yang, Man‐Fung Yuen, Henry Lik‐Yuen Chan et al. · The Lancet Oncology · 2011 · 660 citations · Full text

Medicine, Biostatistics, Oncology +14

Hepatitis B Reactivation in Patients With Previous Hepatitis B Virus Exposure Undergoing Rituximab-Containing Chemotherapy for Lymphoma: A Prospective Study

Wai‐Kay Seto, Thomas S. Y. Chan, Yu‐Yan Hwang et al. · Journal of Clinical Oncology · 2014 · 326 citations

Medicine, Hematology, Oncology +15

Long-Term Lamivudine Therapy Reduces the Risk of Long-Term Complications of Chronic Hepatitis B Infection even in Patients without Advanced Disease

Man‐Fung Yuen, Wai‐Kay Seto, Danny Hoi-Fan Chow et al. · Antiviral Therapy · 2007 · 254 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Treatment cessation of entecavir in Asian patients with hepatitis B e antigen negative chronic hepatitis B: a multicentre prospective study

Wai‐Kay Seto, Aric J. Hui, Vincent Wai‐Sun Wong et al. · Gut · 2014 · 212 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Off-Therapy Response After Nucleos(t)ide Analogue Withdrawal in Patients With Chronic Hepatitis B: An International, Multicenter, Multiethnic Cohort (RETRACT-B Study)

Grishma Hirode, Hannah Choi, Chien‐Hung Chen et al. · Gastroenterology · 2021 · 187 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15